Key Highlights
- ARK Invest acquired 85,485 shares of Palantir totaling approximately $11.15M distributed across five ETFs
- The firm offloaded 44,446 AMD shares valued at roughly $10.52M, trimming semiconductor holdings
- Palantir shares declined approximately 2% on Friday following a sharp 7% drop the previous day
- Investor Michael Burry flagged Palantir as overvalued, pointing to competition from Anthropic’s expansion
- Wedbush analyst Daniel Ives countered Burry’s concerns, reaffirming a Buy recommendation with a $230 target
Cathie Wood’s ARK Invest executed significant portfolio adjustments during April 10-11, 2026, pivoting away from semiconductor exposure while increasing its stake in artificial intelligence software. The transactions were documented in the firm’s publicly available daily trading reports.
The investment management company acquired 85,485 Palantir shares valued at roughly $11.15 million. These holdings were allocated across five different exchange-traded funds: ARKK received 46,455 shares, ARKQ obtained 15,127, ARKW got 11,865, ARKF added 5,973, and ARKX picked up 6,065.
Palantir Technologies Inc., PLTR
Concurrently, ARK divested 44,446 shares of Advanced Micro Devices, representing approximately $10.52 million in value. The semiconductor stock sale was similarly distributed among the identical five fund vehicles.
This rebalancing indicates ARK’s strategic preference for AI-driven software solutions over traditional chip manufacturing businesses.
Market Turbulence Hits Palantir
Palantir’s stock experienced significant volatility during the week preceding ARK’s acquisition. Shares slid about 2% on Friday, compounding a more severe 7% decline registered on Thursday.
The downturn gained momentum following commentary from Michael Burry, the hedge fund manager famous for predicting the 2008 financial crisis. Burry published remarks on X suggesting Palantir’s market valuation has entered speculative excess.
Burry’s thesis centered on competitive threats from Anthropic, the artificial intelligence company, which he believes is capturing market share with its “Mythos” model and accelerating customer adoption. Wood appeared to view the price weakness as an attractive entry point.
ARK additionally liquidated 75,389 shares of Strata Critical Medical worth $305,325, extending a recent pattern of reducing exposure to this holding.
Wall Street Voices Conflicting Views
Burry’s bearish outlook hasn’t gained universal acceptance among market professionals. Daniel Ives from Wedbush Securities characterized Burry’s perspective as detached from operational realities.
Ives maintained his positive stance on Palantir with an unchanged Buy rating and $230 price objective. He highlighted the company’s impressive 137% year-over-year expansion in U.S. Commercial segment revenue as validation of its enduring market strength.
Benchmark analyst Yi Fu Lee takes a more measured position. Lee contends that Palantir’s elevated valuation multiples require continued flawless operational performance to support current share prices.
The broader Wall Street consensus currently leans toward a Moderate Buy recommendation. This aggregate rating reflects 14 Buy recommendations, 5 Hold ratings, and 2 Sell opinions.
The mean analyst price target following the recent market turbulence stands at $194.61, implying potential appreciation of roughly 52% from Friday’s closing level.
Advanced Micro Devices stock advanced 3.55% on the same trading session when ARK completed its divestment.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
